Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1960 2
1961 3
1963 1
1964 2
1969 1
1970 1
1971 4
1972 1
1973 1
1975 4
1983 1
1988 1
1989 2
1992 1
1994 1
1996 3
1998 1
1999 2
2000 3
2001 1
2002 2
2003 4
2004 2
2005 1
2006 3
2007 2
2008 6
2009 7
2011 2
2012 2
2013 1
2014 4
2015 7
2016 3
2017 4
2018 5
2019 5
2020 3
2021 6
2022 5
2023 5
2024 7
2025 1
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

115 results

Results by year

Filters applied: . Clear all
Page 1
Spironolactone and agranulocytosis.
Hui CH, Das PK, Horvath N. Hui CH, et al. Among authors: horvath n. Aust N Z J Med. 2000 Aug;30(4):515. doi: 10.1111/j.1445-5994.2000.tb02066.x. Aust N Z J Med. 2000. PMID: 10985525 No abstract available.
Age-related mesenchymal stromal cell senescence is associated with progression from MGUS to multiple myeloma.
Plakhova N, Panagopoulos V, Cantley MD, Trainor LJ, Hewett DR, Clark KC, Gardiner J, Yong A, Lee C, Horvath N, Croucher PI, Cakouros D, Stewart SA, Gronthos S, Zannettino ACW, Mrozik KM, Vandyke K. Plakhova N, et al. Among authors: horvath n. Leukemia. 2025 Jun;39(6):1464-1475. doi: 10.1038/s41375-025-02621-7. Epub 2025 Apr 22. Leukemia. 2025. PMID: 40263435 Free PMC article.
TP53 mutation in therapy-related myeloid neoplasm defines a distinct molecular subtype.
Hiwase D, Hahn C, Tran ENH, Chhetri R, Baranwal A, Al-Kali A, Sharplin K, Ladon D, Hollins R, Greipp P, Kutyna M, Alkhateeb H, Badar T, Wang P, Ross DM, Singhal D, Shanmuganathan N, Bardy P, Beligaswatte A, Yeung D, Litzow MR, Mangaonkar A, Giri P, Lee C, Yong A, Horvath N, Singhal N, Gowda R, Hogan W, Gangat N, Patnaik M, Begna K, Tiong IS, Wei A, Kumar S, Brown A, Scott H, Thomas D, Kok CH, Tefferi A, Shah MV. Hiwase D, et al. Among authors: horvath n. Blood. 2023 Mar 2;141(9):1087-1091. doi: 10.1182/blood.2022018236. Blood. 2023. PMID: 36574363 Free article. No abstract available.
Daratumumab, cyclophosphamide, bortezomib, and dexamethasone for transplant-ineligible myeloma: AMaRC 03-16.
Mollee P, Reynolds J, Janowski W, Quach H, Campbell P, Gibbs S, Lee S, Lee E, Taylor K, Cochrane T, Wallington-Gates C, Kwok F, Weber N, Kerridge I, Weston H, Ho PJ, Leahy MF, Horvath N, Spencer A. Mollee P, et al. Among authors: horvath n. Blood Adv. 2024 Jul 23;8(14):3721-3730. doi: 10.1182/bloodadvances.2023012539. Blood Adv. 2024. PMID: 38739707 Free PMC article. Clinical Trial.
Management of systemic AL amyloidosis: recommendations of the Myeloma Foundation of Australia Medical and Scientific Advisory Group.
Weber N, Mollee P, Augustson B, Brown R, Catley L, Gibson J, Harrison S, Ho PJ, Horvath N, Jaksic W, Joshua D, Quach H, Roberts AW, Spencer A, Szer J, Talaulikar D, To B, Zannettino A, Prince HM. Weber N, et al. Among authors: horvath n. Intern Med J. 2015 Apr;45(4):371-82. doi: 10.1111/imj.12566. Intern Med J. 2015. PMID: 25169210 Review.
[Botulinum toxin treatment in children with cerebral palsy].
Terebessy T, Domos G, Hevér D, Horváth N, Kiss S, Szőke G. Terebessy T, et al. Among authors: horvath n. Orv Hetil. 2019 Jul;160(28):1105-1111. doi: 10.1556/650.2019.31415. Orv Hetil. 2019. PMID: 31280598 Hungarian.
115 results